D M Lathers
Overview
Explore the profile of D M Lathers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Young M, Wright M, Vellody K, Lathers D
Int J Immunopharmacol
. 2003 Mar;
21(10):675-88.
PMID: 12609462
Tumor presence is detrimental to the development of antigen-presenting dendritic cells. Since dendritic cells can arise from CD34+ precursor cells, the present study assessed the capacity of bone marrow CD34+...
2.
Lathers D, Clark J, Achille N, Young M
Hum Immunol
. 2001 Nov;
62(11):1282-93.
PMID: 11704292
Patients with head and neck squamous cell carcinoma (HNSCC) have profound immune defects. These defects are associated with a poor prognosis and are mediated, in part, by an increased number...
3.
Young M, Kolesiak K, Achille N, Meisinger J, Gonzalez E, Liu S, et al.
Cancer Immunol Immunother
. 2001 Sep;
50(6):315-20.
PMID: 11570585
Tumor development and aging can each alter immune competence. The present study aimed to determine the impact of Lewis lung carcinoma (LLC) presence on immune parameters of middle-aged (averaging 6.5...
4.
Lathers D, Achille N, Kolesiak K, Hulett K, Sparano A, Petruzzelli G, et al.
Otolaryngol Head Neck Surg
. 2001 Sep;
125(3):205-12.
PMID: 11555755
Objectives: This study determined whether mobilization of immune inhibitory CD34+ cells by head and neck squamous cell carcinomas (HNSCC) is most prominent in patients who are node positive and whether...
5.
Young M, Petruzzelli G, Kolesiak K, Achille N, Lathers D, Gabrilovich D
Hum Immunol
. 2001 Apr;
62(4):332-41.
PMID: 11295465
CD34(+) progenitor cells have previously been shown to be mobilized in patients with squamous cell carcinoma of the head and neck (HNSCC). The present study showed that these CD34(+) cells...
6.
Pandit R, Lathers D, Beal N, Garrity T, Young M
Ann Otol Rhinol Laryngol
. 2000 Aug;
109(8 Pt 1):749-54.
PMID: 10961808
Patients with head and neck squamous cell carcinoma (HNSCC) have profound defects in their immune defenses. Using immunofluorescent staining and flow cytometric analysis, we found that most patients with HNSCC...
7.
Wiers K, Lathers D, Wright M, Young M
J Immunother
. 2000 Feb;
23(1):115-24.
PMID: 10687144
Tumor growth can increase the number of immature bone marrow-derived CD34+ cells that exhibit natural suppressor (NS) activity toward T-cell function. Using a metastatic Lewis lung carcinoma (LLC-LN7) tumor model,...
8.
Lathers D, Lubbers E, Beal N, Wright M, Young M
Hum Immunol
. 2000 Jan;
60(12):1207-15.
PMID: 10626734
Patients with head and neck squamous cell carcinoma (HNSCC) have profound immune defects mediated, in part, by an increased number of immune suppressive CD34+ progenitor cells in their peripheral blood...
9.
Young M, Lathers D
Int J Immunopharmacol
. 1999 Jul;
21(4):241-52.
PMID: 10408632
Patients with squamous cell carcinomas of the head and neck (HNSCC) have profound defects in their immune defenses. We have shown that among the mechanisms that contribute to this immune...
10.
Young M, Wright M, Lathers D, Messingham K
Int J Cancer
. 1999 Jul;
82(4):609-15.
PMID: 10404079
Tumors, such as the murine Lewis lung carcinoma (LLC), produce granulocyte-macrophage colony-stimulating factor (GM-CSF), which increases the proportion of CD34(+) hematopoietic progenitor cells in the bone marrow and in the...